The Safety and Efficacy of Radiation Therapy with Concurrent Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin-Based Systemic Therapy for Multiple Myeloma-Reference-Cited by-同舟云学术

The Safety and Efficacy of Radiation Therapy with Concurrent Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin-Based Systemic Therapy for Multiple Myeloma

Published:2021-09 Issue: Volume: Page:
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Nehlsen Anthony D.^ORCID,Sindhu Kunal K.^ORCID,Moshier Erin,Richter Joshua,Richard Shambavi,Chari Ajai,Sanchez Larysa,Parekh Samir,Cho Hearn Jay,Jagannath Sundar,Dharmarajan Kavita^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference26 articles.

1. Esophageal granular cell tumor: a case report and review of literature;Thumallapally;Cureus,2016

2. Global burden of multiple myeloma: a systematic analysis for the global burden of disease study;Cowan;JAMA Oncol,2016

3. DCEP for relapsed or refractory multiple myeloma after therapy with novel agents;Park;Ann Hematol,2014

4. Dexamethasone, cyclophosphamide, etoposide and cisplatin (DCEP) for relapsed or refractory multiple myeloma patients;Dadacaridou;J Buon,2007

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Remineralization Rate of Lytic Lesions of the Spine in Multiple Myeloma Patients Undergoing Radiation Therapy;Global Spine Journal;2024-06-10

2. Radiotherapy in Combination with Systemic Therapy for Multiple Myeloma—A Critical Toxicity Evaluation in the Modern Treatment Era;Cancers;2023-05-25

3. Cisplatin in cancer treatment;Biochemical Pharmacology;2022-12

4. Phase II trial of daratumumab with DCEP in relapsed/refractory multiple myeloma patients with extramedullary disease;Journal of Hematology & Oncology;2022-10-23